Journal profile · Nursing-Nursing (all)
JBI Evidence Synthesis
ISSN 2689-8381 · Wolters Kluwer Health
JBI Evidence Synthesis: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 6.8 (journal website); JCR Q1 (journal website); hybrid open access; 162 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
JBI Evidence Synthesis is published by Wolters Kluwer Health and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Meta-analysis and systematic reviews, Health Policy Implementation Science and Nursing education and management, together about 24.5% of its articles. Its main subfields are General Health Professions. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Nursing-Nursing (all)
Editor-in-chief Edoardo AromatarisPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Meta-analysis and systematic reviewsDecision Sciences9%
- Health Policy Implementation ScienceHealth Professions8.5%
- Nursing education and managementNursing7.1%
- Health Sciences Research and EducationHealth Professions5.5%
- Family and Patient Care in Intensive Care UnitsHealth Professions5.3%
- Geriatric Care and Nursing HomesHealth Professions5%
- Maternal Mental Health During Pregnancy and PostpartumMedicine4.6%
- Palliative Care and End-of-Life IssuesMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Health Care Sciences & Services | Zone 4 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Health Care Sciences & Services | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
JCR / CiteScore quartiles on the journal's website
- JCR Q1 · HEALTH CARE SCIENCES & SERVICES · rank 11/194
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 6.8Publisher website ·
- CiteScore 2026-06
- 8LetPub ·
- SJR 2026-06
- 2.04LetPub ·
- SNIP 2026-06
- 2.43LetPub ·
- h-index
- 39OpenAlex ·
- i10-index
- 181OpenAlex ·
- 2-year mean citedness
- 4.68OpenAlex ·
- Self-citation rate
- 4.4%LetPub ·
- Share of gold OA articles
- 13.25%LetPub ·
Volume
- Articles per year
- 148LetPub ·
Articles by year OpenAlex count · 1,246 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 139 | 29 | 13 |
| 2025 | 162 | 37 | 544 |
| 2024 | 136 | 46 | 1,488 |
| 2023 | 173 | 40 | 2,034 |
| 2022 | 168 | 38 | 6,094 |
| 2021 | 220 | 39 | 1,959 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Wolters Kluwer Health
- ISSN
- 2689-8381
- Latest issue on the website
- Volume 24, Issue 9 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about JBI Evidence Synthesis
What CAS zone is JBI Evidence Synthesis in?
In the 2025 upgraded edition of the CAS Journal Ranking, JBI Evidence Synthesis is in Zone 4 of Medicine, and in Zone 4 of the minor category Health Care Sciences & Services. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of JBI Evidence Synthesis?
The journal's website gives an impact factor of 6.8; this is the journal's own figure, as LetPub lists none for it; CiteScore 8, h-index 39.
What JCR quartile is JBI Evidence Synthesis in?
The journal's website gives JCR Q1; by category, HEALTH CARE SCIENCES & SERVICES Q1 (11/194). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Which databases index JBI Evidence Synthesis?
According to LetPub and DOAJ records, JBI Evidence Synthesis is indexed in ESCI and Scopus.
Is JBI Evidence Synthesis open access, and what is the APC?
JBI Evidence Synthesis is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .